Reality Check

MMIT Reality Check on Endometriosis (June 2020)

According to our recent payer coverage analysis for endometriosis treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help make sense of this new r...
0 Comments

MMIT Reality Check on Chronic Idiopathic Constipation (June 2020)

According to our recent payer coverage analysis for chronic idiopathic constipation treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help make s...
0 Comments

MMIT Reality Check on Narcolepsy (May 2020)

According to our recent payer coverage analysis for narcolepsy treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help make sense of this new rese...
0 Comments

MMIT Reality Check on Low Testosterone (May 2020)

According to our recent payer coverage analysis for low testosterone treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help make sense of this ne...
0 Comments

MMIT Reality Check on Pain Narcotic Opioid (May 2020)

According to our recent payer coverage analysis for pain narcotic opioid treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help make sense of thi...
0 Comments

MMIT Reality Check on Anemia — Chronic Kidney Disease (May 2020)

According to our recent payer coverage analysis for anemia treatments due to chronic kidney disease, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help m...
0 Comments

MMIT Reality Check on Ophthalmic Anti-Inflammatory (Apr 2020)

According to our recent payer coverage analysis for ophthalmic anti-inflammatory treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help make sens...
0 Comments

MMIT Reality Check on Juvenile Idiopathic Arthritis (Apr 2020)

By AIS Health Staff
According to our recent payer coverage analysis for juvenile idiopathic arthritis treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help make sen...
0 Comments

MMIT Reality Check on Acute Myeloid Leukemia (Apr 2020)

According to our recent payer coverage analysis for acute myeloid leukemia treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help make sense of t...
0 Comments

MMIT Reality Check on COPD (Apr 2020)

According to our recent payer coverage analysis for glaucoma treatments, combined with news from key healthcare influencers, market access is shifting in this drug landscape. To help make sense of this new resear...
0 Comments